The Stunning Golden Parachutes of Juno's $9B Celgene Deal Post author:Sam Post published:February 4, 2018 Post category:BioPharma Juno’s Hans Bishop will take home $287M after Celgene acquired his company. Source: BioSpace You Might Also Like <b>BeneVir</b> Granted Patent Protecting Lead Oncolytic Immunotherapy Stealth-1H And Other Platform Assets April 24, 2017 Deal Spree Continues as Allergan Inks $2.47 Billion Deal for This Bay Area Biotech February 12, 2017 Reverse Merger With Gives Cerulean Execs a Parting Gift—Bonuses March 21, 2017
<b>BeneVir</b> Granted Patent Protecting Lead Oncolytic Immunotherapy Stealth-1H And Other Platform Assets April 24, 2017
